Over-expression of MFSD2A in transfected lung cancer cell lines was associated with reduced clonogenicity in vitro and diminished tumorigenicity in vivo, an effect due likely to the ability of MFSD2A to block the cell cycle in the G1 phase and to impair adhesive and migratory properties. Here, MFSD2A is linked to lung cancer.